SLC7A11 and Parkinson disease: These results provide novel mechanistic insights into the pathophysiological connection between diabetes‐associated hyperglycemia and PD development, while simultaneously identifying SLC7A11 as a promising therapeutic target for the clinical management of PD in diabetic populations.